University of Chicago - American School Building
Chicago, Illinois, 60637, United States
NCT Number: NCT06211374
The aim of this study is to evaluate the effectiveness and feasibility of evidence-based interventions in individuals living with mild to moderate primary progressive aphasia (PPA) that address communication-focused outcomes.
This study is active but is not currently recruiting participants.
18 year–100 year
All sexes
Interventional
Not applicable
Chicago, Illinois, 60637, United States
The purpose of this study is to evaluate the effectiveness and feasibility of evidence-based interventions in individuals living with mild to moderate primary progressive aphasia (PPA) that address communication-focused outcomes. The study team aims to enhance the personal relevance and therapeutic impact of goal attainment scaling (GAS) while building self-efficacy within a self-management framework.
This study will be a continuation of one of the largest non-pharmacologic intervention studies for individuals with PPA to date. It will add critical information regarding the effectiveness of telepractice interventions for communication disorders in adults with primary progressive aphasia specifically, and in dementia more broadly. The goal of this study is to maximize functional communication and life participation for the participants.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(person with PPA):
Inclusion criteria
(Co-enrolled communication partner):
Exclusion criteria
Evidence-based speech language therapy treatment will be compared and contrasted in the two arms of the study.
Time frame: Time Frame: 2 assessment time points through study completion, an average of 5 months, including change over time
Goal Attainment Scaling, a 7-point rating scale with -3 representing 'no longer participating' and +3 representing 'exceeded goal'. Higher scores indicate better progress in goal achievement.
University of Chicago
Other
Communication Bridge: Optimizing an Evidence-based Intervention for Individuals With Primary Progressive Aphasia
Acronym: CB3_1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06191198
Alzheimer Disease, Aphasia
Chicago, Illinois, United States
View Trial DetailsNCT03371706
Alzheimer Disease, Aphasia
Chicago, Illinois, United States
View Trial DetailsNCT05741853
Alzheimer Disease, Aphasia
Austin, Texas, United States
View Trial DetailsNCT05697380
Alzheimer Disease, Aphasia
Chicago, Illinois, United States
View Trial Details